SoftBank Robotics Europe

SoftBank Robotics Europe, formerly Aldebaran Robotics, designs and manufactures humanoid robots for education, research, health, distribution, tourism, business applications, and home use. The company serves customers worldwide and focuses on interactive robotics that assist professionals and individuals. Founded in 2005, it is based in Paris, France, with additional offices in France, Japan, the United States, and China, and operates as a subsidiary of SoftBank Group.

Karim Abouzahr

Director, SoftBank Europe Ventures

Kristin Bannon

Investment Director, SoftBank Investment Advisers

Jonathan Bullock

COO and Managing Director

John Cassidy

Investment Director, Life Sciences and HealthTech

Tom Cheung

Partner, Americas

Serena Dayal

Partner, Americas

Angela Du

Partner, Americas

Colin Fan

Managing Partner, SoftBank Investment Advisers

Ted Fike

Director, Americas

Ronald Fisher

Vice Chairman

Kunihiro Fujinaga

Managing Executive Officer

Navneet Govil

Managing Partner, CFO

Ayush Jain

Investment Vice President

Lydia Jett

Managing Partner

Sumer Juneja

Managing Partner and Head of EMEA and India Investing

Robert Kaplan

Partner, Americas

Gosia Karas

Investor

Eylul Kayin

Vice President

Chris Lee

Partner, Asia

Anna Lo

Director, Americas

Amit Lubovsky

Investor

Jimi Macdonald

Director

Makizono Keiichi

Executive Officer and CIO

Kentaro Matsui

Managing Partner

Ken Miyauchi

Representative Director and Senior Executive Vice President

Greg Moon

Executive Managing Partner

Karol Niewiadomski

Partner

Shu Nyatta

Managing Partner

Max Ohrstrand

Partner, EMEA

Vikas Parekh

Managing Partner

Ben Parton

Director of Deals and Transactions

Yanni Pipilis

Managing Partner

Narendra Rathi

Director, Asia

Brett Rochkind

Managing Partner

Brett Rochkind

Managing Partner

Priya Saiprasad

Partner

Masayoshi Son

Founder

Ram Trichur

Partner

Ervin Tu

Partner, Americas

Aaron Wong

Vice President

Tim Yap

Director, EMEA

Kenichi Yoshida

Chief Business Officer and Executive Vice President

Linda Yu

Vice President, Vision Fund

Andrew Zloto

Partner, Americas

Past deals in Idaho

Zymergen

Series D in 2020
Zymergen, Inc. is a biotechnology company that focuses on researching, developing, and manufacturing microbes for various industries, including agriculture, chemicals, materials, pharmaceuticals, electronics, and personal care. Founded in 2013 and headquartered in Emeryville, California, Zymergen employs a platform that integrates automation, machine learning, and genomics to enhance the efficiency of microbial strain optimization and production processes. This technology enables the company to improve existing manufacturing strains and facilitates the development of new products by engineering novel molecules from microbes. With additional offices in Boise, Idaho; Medford, Massachusetts; Seattle, Washington; and Tokyo, Japan, Zymergen aims to partner with nature to create innovative materials and products that deliver significant value across multiple sectors.

Zymergen

Series C in 2018
Zymergen, Inc. is a biotechnology company that focuses on researching, developing, and manufacturing microbes for various industries, including agriculture, chemicals, materials, pharmaceuticals, electronics, and personal care. Founded in 2013 and headquartered in Emeryville, California, Zymergen employs a platform that integrates automation, machine learning, and genomics to enhance the efficiency of microbial strain optimization and production processes. This technology enables the company to improve existing manufacturing strains and facilitates the development of new products by engineering novel molecules from microbes. With additional offices in Boise, Idaho; Medford, Massachusetts; Seattle, Washington; and Tokyo, Japan, Zymergen aims to partner with nature to create innovative materials and products that deliver significant value across multiple sectors.

Zymergen

Series B in 2016
Zymergen, Inc. is a biotechnology company that focuses on researching, developing, and manufacturing microbes for various industries, including agriculture, chemicals, materials, pharmaceuticals, electronics, and personal care. Founded in 2013 and headquartered in Emeryville, California, Zymergen employs a platform that integrates automation, machine learning, and genomics to enhance the efficiency of microbial strain optimization and production processes. This technology enables the company to improve existing manufacturing strains and facilitates the development of new products by engineering novel molecules from microbes. With additional offices in Boise, Idaho; Medford, Massachusetts; Seattle, Washington; and Tokyo, Japan, Zymergen aims to partner with nature to create innovative materials and products that deliver significant value across multiple sectors.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.